- Home
- TARS vs REVG Comparison
TARS vs REVG Comparison
Compare TARS & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- REVG
- Stock Information
- Founded
- TARS 2016
- REVG 2008
- Country
- TARS United States
- REVG United States
- Employees
- TARS N/A
- REVG N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- REVG Auto Manufacturing
- Sector
- TARS Health Care
- REVG Consumer Discretionary
- Exchange
- TARS Nasdaq
- REVG Nasdaq
- Market Cap
- TARS 2.8B
- REVG 2.9B
- IPO Year
- TARS 2020
- REVG 2017
- Fundamental
- Price
- TARS $67.56
- REVG $61.29
- Analyst Decision
- TARS Strong Buy
- REVG Hold
- Analyst Count
- TARS 7
- REVG 4
- Target Price
- TARS $69.43
- REVG $53.00
- AVG Volume (30 Days)
- TARS 613.1K
- REVG 552.6K
- Earning Date
- TARS 11-04-2025
- REVG 12-10-2025
- Dividend Yield
- TARS N/A
- REVG 0.39%
- EPS Growth
- TARS N/A
- REVG N/A
- EPS
- TARS N/A
- REVG 2.12
- Revenue
- TARS $295,521,000.00
- REVG $2,397,000,000.00
- Revenue This Year
- TARS $139.46
- REVG $4.82
- Revenue Next Year
- TARS $49.91
- REVG $8.06
- P/E Ratio
- TARS N/A
- REVG $28.95
- Revenue Growth
- TARS 254.45
- REVG N/A
- 52 Week Low
- TARS $38.51
- REVG $25.76
- 52 Week High
- TARS $76.81
- REVG $64.47
- Technical
- Relative Strength Index (RSI)
- TARS 54.32
- REVG 65.98
- Support Level
- TARS $65.30
- REVG $57.91
- Resistance Level
- TARS $74.83
- REVG $59.48
- Average True Range (ATR)
- TARS 2.87
- REVG 1.59
- MACD
- TARS -0.99
- REVG 0.46
- Stochastic Oscillator
- TARS 19.64
- REVG 87.71
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About REVG REV Group Inc.
REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.